Glenmede Trust’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-5,534
| Closed | -$92K | – | 2510 |
|
|
2018
Q1 | $92K | Hold |
5,534
| – | – | ﹤0.01% | 1424 |
|
|
2017
Q4 | $92K | Buy |
5,534
+5,338
| +2,723% | +$88.7K | ﹤0.01% | 1424 |
|
|
2017
Q3 | $3K | Hold |
196
| – | – | ﹤0.01% | 2532 |
|
|
2017
Q2 | $2K | Hold |
196
| – | – | ﹤0.01% | 2542 |
|
|
2017
Q1 | $2K | Buy |
196
+157
| +403% | +$1.6K | ﹤0.01% | 2542 |
|
|
2016
Q4 | $0 | Hold |
39
| – | – | ﹤0.01% | 2712 |
|
|
2016
Q3 | $0 | Hold |
39
| – | – | ﹤0.01% | 2741 |
|
|
2016
Q2 | $0 | Sell |
39
-343
| -90% | – | ﹤0.01% | 2808 |
|
|
2016
Q1 | $11K | Buy |
382
+95
| +33% | +$2.74K | ﹤0.01% | 2026 |
|
|
2015
Q4 | $11K | Hold |
287
| – | – | ﹤0.01% | 2051 |
|
|
2015
Q3 | $9K | Sell |
287
-4,314
| -94% | -$135K | ﹤0.01% | 2152 |
|
|
2015
Q2 | $210K | Buy |
4,601
+148
| +3% | +$6.76K | ﹤0.01% | 1202 |
|
|
2015
Q1 | $208K | Buy |
+4,453
| New | +$208K | ﹤0.01% | 1235 |
|
|
2014
Q3 | – | Sell |
-6,304
| Closed | -$189K | – | 2542 |
|
|
2014
Q2 | $189K | Hold |
6,304
| – | – | ﹤0.01% | 1191 |
|
|
2014
Q1 | $166K | Sell |
6,304
-13,375
| -68% | -$352K | ﹤0.01% | 1239 |
|
|
2013
Q4 | $494K | Hold |
19,679
| – | – | 0.01% | 865 |
|
|
2013
Q3 | $402K | Hold |
19,679
| – | – | ﹤0.01% | 886 |
|
|
2013
Q2 | $392K | Buy |
+19,679
| New | +$392K | ﹤0.01% | 840 |
|